Boston Scientific's NexStent Carotid Stent and Monorail Delivery System has been approved for use in patients with carotid artery disease who are at high risk for surgery.

The NexStent Carotid Stent is a laser-cut, nitinol stent with a rolled sheet design that enables one stent size to adapt to multiple configurations in tapered or nontapered vessel configurations. Its self-sizing feature is designed to provide adaptability when treating lesions in the carotid artery, and its closed-cell configuration is designed to increase lesion coverage and provide a smooth inner lumen to help facilitate delivery and retrieval of ancillary devices.

According to the company, the NexStent has been shown in studies to have excellent outcomes at 1 month through 1 year in patients with a wide range of lesions and vessel anatomy.

Source